17 reports of this reaction
2.3% of all TOLNAFTATE 1% reports
#2 most reported adverse reaction
ARTHRALGIA is the #2 most commonly reported adverse reaction for TOLNAFTATE 1%, manufactured by Meijer Distribution Inc. There are 17 FDA adverse event reports linking TOLNAFTATE 1% to ARTHRALGIA. This represents approximately 2.3% of all 724 adverse event reports for this drug.
Patients taking TOLNAFTATE 1% who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is a less commonly reported adverse event for TOLNAFTATE 1%, but still significant enough to appear in the safety profile.
In addition to arthralgia, the following adverse reactions have been reported for TOLNAFTATE 1%:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 17 FDA reports for TOLNAFTATE 1%. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 2.3% of all adverse event reports for TOLNAFTATE 1%, making it one of the most commonly reported side effect.
If you experience arthralgia while taking TOLNAFTATE 1%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.